S&P 500   4,287.10 (+0.31%)
DOW   33,983.25 (+0.01%)
QQQ   330.13 (+0.50%)
AAPL   174.55 (+0.00%)
MSFT   291.28 (-0.01%)
META   175.31 (+0.26%)
GOOGL   120.56 (+0.84%)
AMZN   142.70 (+0.42%)
TSLA   917.45 (+0.60%)
NVDA   187.90 (+2.48%)
NIO   20.13 (+0.25%)
BABA   91.26 (+1.66%)
AMD   100.30 (+2.07%)
MU   63.05 (+2.32%)
T   18.47 (+0.27%)
CGC   3.94 (-2.96%)
F   16.04 (+0.06%)
GE   79.57 (-0.44%)
DIS   122.99 (+0.15%)
AMC   20.14 (-5.71%)
PYPL   99.14 (-0.28%)
PFE   49.06 (-0.43%)
NFLX   246.43 (+2.19%)
S&P 500   4,287.10 (+0.31%)
DOW   33,983.25 (+0.01%)
QQQ   330.13 (+0.50%)
AAPL   174.55 (+0.00%)
MSFT   291.28 (-0.01%)
META   175.31 (+0.26%)
GOOGL   120.56 (+0.84%)
AMZN   142.70 (+0.42%)
TSLA   917.45 (+0.60%)
NVDA   187.90 (+2.48%)
NIO   20.13 (+0.25%)
BABA   91.26 (+1.66%)
AMD   100.30 (+2.07%)
MU   63.05 (+2.32%)
T   18.47 (+0.27%)
CGC   3.94 (-2.96%)
F   16.04 (+0.06%)
GE   79.57 (-0.44%)
DIS   122.99 (+0.15%)
AMC   20.14 (-5.71%)
PYPL   99.14 (-0.28%)
PFE   49.06 (-0.43%)
NFLX   246.43 (+2.19%)
S&P 500   4,287.10 (+0.31%)
DOW   33,983.25 (+0.01%)
QQQ   330.13 (+0.50%)
AAPL   174.55 (+0.00%)
MSFT   291.28 (-0.01%)
META   175.31 (+0.26%)
GOOGL   120.56 (+0.84%)
AMZN   142.70 (+0.42%)
TSLA   917.45 (+0.60%)
NVDA   187.90 (+2.48%)
NIO   20.13 (+0.25%)
BABA   91.26 (+1.66%)
AMD   100.30 (+2.07%)
MU   63.05 (+2.32%)
T   18.47 (+0.27%)
CGC   3.94 (-2.96%)
F   16.04 (+0.06%)
GE   79.57 (-0.44%)
DIS   122.99 (+0.15%)
AMC   20.14 (-5.71%)
PYPL   99.14 (-0.28%)
PFE   49.06 (-0.43%)
NFLX   246.43 (+2.19%)
S&P 500   4,287.10 (+0.31%)
DOW   33,983.25 (+0.01%)
QQQ   330.13 (+0.50%)
AAPL   174.55 (+0.00%)
MSFT   291.28 (-0.01%)
META   175.31 (+0.26%)
GOOGL   120.56 (+0.84%)
AMZN   142.70 (+0.42%)
TSLA   917.45 (+0.60%)
NVDA   187.90 (+2.48%)
NIO   20.13 (+0.25%)
BABA   91.26 (+1.66%)
AMD   100.30 (+2.07%)
MU   63.05 (+2.32%)
T   18.47 (+0.27%)
CGC   3.94 (-2.96%)
F   16.04 (+0.06%)
GE   79.57 (-0.44%)
DIS   122.99 (+0.15%)
AMC   20.14 (-5.71%)
PYPL   99.14 (-0.28%)
PFE   49.06 (-0.43%)
NFLX   246.43 (+2.19%)
OTCMKTS:PETV

PetVivo - PETV Stock Forecast, Price & News

$2.57
+0.05 (+1.98%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.50
$2.63
50-Day Range
$1.58
$2.63
52-Week Range
$1.20
$5.14
Volume
35,673 shs
Average Volume
27,715 shs
Market Capitalization
$25.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

PetVivo MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
172.4% Upside
$7.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.46mentions of PetVivo in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$17,700 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.04 out of 5 stars

PETV stock logo

About PetVivo (OTCMKTS:PETV) Stock

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Receive PETV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter.

PETV Stock News Headlines

Investors Look to Capitalize on the Budding Green Revolution
Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors.
Investors Look to Capitalize on the Budding Green Revolution
Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors.
See More Headlines
Receive PETV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter.

PETV Company Calendar

Last Earnings
11/15/2021
Today
8/18/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PETV
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+172.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-5,010,000.00
Net Margins
-3,817.65%
Pretax Margin
-3,817.06%

Debt

Sales & Book Value

Annual Sales
$120,000.00
Book Value
$0.42 per share

Miscellaneous

Free Float
6,492,000
Market Cap
$25.80 million
Optionable
Not Optionable
Beta
1.96














PETV Stock - Frequently Asked Questions

Should I buy or sell PetVivo stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetVivo in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" PETV shares.
View PETV analyst ratings
or view top-rated stocks.

What is PetVivo's stock price forecast for 2022?

1 equities research analysts have issued 12 month price objectives for PetVivo's stock. Their PETV share price forecasts range from $7.00 to $7.00. On average, they anticipate the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 172.4% from the stock's current price.
View analysts price targets for PETV
or view top-rated stocks among Wall Street analysts.

How have PETV shares performed in 2022?

PetVivo's stock was trading at $3.77 at the beginning of 2022. Since then, PETV shares have decreased by 31.8% and is now trading at $2.57.
View the best growth stocks for 2022 here
.

How were PetVivo's earnings last quarter?

PetVivo Holdings, Inc. (OTCMKTS:PETV) issued its earnings results on Monday, November, 15th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.05. The business earned $0.01 million during the quarter. PetVivo had a negative trailing twelve-month return on equity of 99.68% and a negative net margin of 3,817.65%.

What is PetVivo's stock symbol?

PetVivo trades on the OTCMKTS under the ticker symbol "PETV."

Who are PetVivo's major shareholders?

PetVivo's stock is owned by a number of institutional and retail investors. Top institutional investors include Truist Financial Corp (1.40%). Insiders that own company stock include James Joseph Martin, James Rudolph Martin, John Lai, Robert J Folkes and Scott Mitchell Johnson.
View institutional ownership trends
.

How do I buy shares of PetVivo?

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetVivo's stock price today?

One share of PETV stock can currently be purchased for approximately $2.57.

How much money does PetVivo make?

PetVivo (OTCMKTS:PETV) has a market capitalization of $25.80 million and generates $120,000.00 in revenue each year. The company earns $-5,010,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.

How can I contact PetVivo?

PetVivo's mailing address is 5251 EDINA INDUSTRIAL BLVD, EDINA MN, 55439. The official website for the company is www.petvivo.com. The company can be reached via phone at (952) 405-6216 or via email at investors@petvivo.com.

This page (OTCMKTS:PETV) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.